I have the textbook data I need. Here are the fully written long-answer exam questions, age-stratified, from diagnosis to full management:
Long Answer Questions: Pediatric Infectious Diseases - Age-Specific Scenarios
QUESTION 1 - Neonatal Period (0-28 days)
Scenario
A 3-day-old male neonate, born at term by normal vaginal delivery after prolonged rupture of membranes (>18 hours) with maternal fever during labour, is brought with poor feeding, lethargy, temperature instability (axillary temp 38.2°C), grunting, and mild jaundice. Blood glucose is 2.1 mmol/L. His mother was not screened for Group B Streptococcus (GBS) antenatally.
Q: Discuss the diagnosis, investigations, and full management of this neonate.
ANSWER
A. Diagnosis
Primary Diagnosis: Early-Onset Neonatal Sepsis (EONS)
This is defined as sepsis presenting within the first 7 days of life (most within 72 hours), typically fulminant, and directly linked to maternal/perinatal risk factors.
Risk factors present in this case:
- Prolonged rupture of membranes >18 hours (single most important risk factor)
- Maternal fever in labour (chorioamnionitis)
- Unknown GBS status
- Male sex (males have higher sepsis susceptibility)
Clinical features consistent with neonatal sepsis (Tintinalli's, Table 116-3):
| Feature | Present in this baby |
|---|
| Temperature instability (fever OR hypothermia) | Fever 38.2°C |
| CNS dysfunction - lethargy, irritability | Lethargy |
| Respiratory distress - apnea, grunting | Grunting |
| Feeding disturbance | Poor feeding |
| Jaundice | Present |
Important: Nuchal rigidity and meningeal signs are present in only a minority of neonates with meningitis - their absence does NOT exclude CNS infection.
B. Differential Diagnoses
- Neonatal meningitis - always co-investigate; cannot be excluded without LP
- Neonatal pneumonia - shares organisms with EONS; respiratory signs may dominate
- Metabolic disease - inborn error of metabolism (rule out with metabolic screen)
- Congenital heart disease - can present with poor feeding and cyanosis
- Neonatal herpes simplex encephalitis - if maternal HSV history; vesicular rash
- Hypoglycaemia alone - blood glucose is low here (2.1 mmol/L) but sepsis must still be excluded
C. Causative Organisms
Early-onset (<7 days):
- Group B Streptococcus (Streptococcus agalactiae) - most common; from maternal vaginal colonization
- Escherichia coli - especially in preterm; K1 antigen strains cause meningitis
- Listeria monocytogenes - uncommon but classically tested; associated with maternal consumption of unpasteurized dairy
- Haemophilus influenzae
Late-onset (7-28 days):
- Same organisms as above, plus Staphylococcus aureus, coagulase-negative Staphylococci (especially NICU/indwelling lines)
- Meningitis more common in late-onset disease
D. Investigations
Septic Screen (Full):
| Investigation | What to look for |
|---|
| FBC | WBC <5,000 or >25,000/mm³, neutropenia, band forms (immature:total neutrophil ratio >0.2) |
| CRP | Raised (>10 mg/L); serial measurement useful |
| Blood culture | 2 sets before antibiotics; most important test |
| Blood glucose | Hypoglycaemia common in sepsis |
| Serum electrolytes + calcium | Hyponatraemia, hypocalcaemia |
| LFTs | Conjugated jaundice → hepatitis, cholestasis in sepsis |
| Coagulation (PT/aPTT) | DIC screen - coagulopathy in severe sepsis |
| Lumbar puncture (LP) | Mandatory in all neonates with suspected sepsis |
| CSF analysis | Cells, glucose, protein, Gram stain, culture |
| Urine (suprapubic aspiration or catheter) | Culture - sterile collection essential in neonates |
| CXR | Pneumonia, ground glass (RDS), cardiomegaly |
| Metabolic screen | If no obvious risk factors and atypical presentation |
CSF interpretation in neonates:
| Parameter | Normal Neonate | Bacterial Meningitis |
|---|
| WBC | <30 cells/mm³ (mostly mono) | >100-1000, polymorphs dominant |
| Glucose | >50% of blood glucose | <40% of blood glucose |
| Protein | <150 mg/dL | >150 mg/dL (often >200) |
| Appearance | Clear | Turbid/cloudy |
E. Management
1. Immediate Stabilisation (ABC)
- Airway: position, suction if needed
- Breathing: supplemental O₂ if SpO₂ <92%; CPAP or intubation if respiratory failure
- Circulation: IV access - umbilical venous catheter if peripheral access fails
- Temperature: incubator/radiant warmer for temperature instability
- Correct hypoglycaemia: 2 mL/kg of 10% dextrose IV bolus, then maintenance glucose infusion
2. Antibiotic Therapy (Start within 1 hour of suspicion)
Empirical regimen for early-onset neonatal sepsis/meningitis:
| Drug | Dose | Coverage |
|---|
| Ampicillin | 50 mg/kg IV q8-12h | GBS, Listeria, some E. coli |
| Gentamicin | 2.5 mg/kg IV q24-36h (adjust for gestational age) | Gram-negatives, synergy with ampicillin |
Critical exam point: Avoid ceftriaxone in neonates - it displaces bilirubin from albumin-binding sites and can precipitate or worsen kernicterus. Use cefotaxime instead if a third-generation cephalosporin is needed (e.g., suspected gram-negative meningitis).
If gram-negative meningitis is strongly suspected: Replace gentamicin with cefotaxime 50 mg/kg IV (better CNS penetration).
If neonatal HSV is suspected (maternal herpes, CSF with lymphocytes + RBCs in non-traumatic LP, vesicles, ill-appearing neonate): Add IV acyclovir 20 mg/kg q8h.
3. Duration of Antibiotics
- Bacteraemia without focus: 10-14 days
- GBS meningitis: 14-21 days (IV)
- Gram-negative meningitis: 21 days (IV)
- Culture-negative sepsis with good clinical response: 5-7 days (can discuss early de-escalation)
4. Supportive Care
- Maintain normothermia, normoglycaemia, normoxia
- Fluid management: 60-80 mL/kg/day day 1, increasing by 10-20 mL/kg/day
- Monitor for DIC, electrolyte disturbances
- Treat seizures: phenobarbitone (loading dose 20 mg/kg IV)
- Assess for complications: hydrocephalus (head circumference daily), hearing loss (OAE/BERA before discharge)
5. Prevention (Exam favourite)
- Intrapartum GBS prophylaxis: IV penicillin G to mother during labour if GBS-positive, prolonged ROM >18h, or maternal fever
- Universal GBS screening at 35-37 weeks gestation
QUESTION 2 - Infant (2 months - 1 year)
Scenario
A 4-month-old girl is brought with 2 days of high fever (39.5°C), increasing irritability, poor feeding, and two episodes of seizures at home. On examination she is lethargic, has a bulging anterior fontanelle, neck stiffness, and a non-blanching petechial rash over the trunk and lower limbs. HR 188/min, RR 52/min.
Q: Discuss the diagnosis, investigations, and management of this infant.
ANSWER
A. Diagnosis
Primary Diagnosis: Bacterial Meningitis with Meningococcaemia (Neisseria meningitidis)
Diagnostic reasoning:
- Age 4 months - classic age for bacterial meningitis (beyond neonatal period, maternal antibody waning)
- High fever + bulging fontanelle + neck stiffness = meningeal irritation + raised ICP
- Non-blanching petechial/purpuric rash = pathognomonic feature of meningococcal disease
- Seizures: indicate cerebral irritation/encephalitis
- Haemodynamic compromise: septic shock component
Meningeal signs in infants:
- Bulging fontanelle (more reliable than neck stiffness in <12 months)
- Kernig's sign (straighten knee with hip flexed → pain/resistance)
- Brudzinski's sign (passive neck flexion → involuntary hip/knee flexion)
- Note: These are present in a minority of neonates but more reliable in older infants
B. Causative Organisms by Age
| Age | Organisms |
|---|
| 0-3 months | GBS, E. coli, Listeria |
| 3 months - 5 years | Neisseria meningitidis, Streptococcus pneumoniae, H. influenzae type b |
| 5-18 years | N. meningitidis, S. pneumoniae |
C. Investigations
Do NOT delay antibiotics for LP if:
- Cardiovascular instability / shock
- Seizures or focal neurology
- GCS <13 or rapidly deteriorating
- Raised ICP signs (papilloedema, unequal pupils)
- Coagulopathy
Order of action: Blood cultures → IV antibiotics → stabilise → LP when safe.
Investigations:
| Test | Expected Findings |
|---|
| Blood culture | N. meningitidis (or pneumococcus) |
| FBC | Leukocytosis (or leukopenia in severe meningococcaemia) |
| CRP/Procalcitonin | Markedly elevated |
| Blood glucose | Needed to interpret CSF glucose |
| Coagulation screen | DIC - prolonged PT, low fibrinogen, thrombocytopenia |
| Electrolytes | SIADH - hyponatraemia |
| LP - CSF analysis | See table below |
| PCR (blood/CSF) | Meningococcal/pneumococcal PCR - positive even after antibiotics |
| CT head | Only before LP if signs of raised ICP |
| Urine culture | Exclude concurrent UTI |
CSF findings - Bacterial vs. Viral Meningitis:
| Bacterial | Viral (Aseptic) | TB |
|---|
| Appearance | Turbid, cloudy | Clear | Clear/xanthochromic |
| WBC | 100-50,000 (mostly PMNs) | 10-500 (lymphocytes) | 10-500 (lymphocytes) |
| Glucose | <40% blood glucose (LOW) | Normal (>50%) | Low (<45 mg/dL) |
| Protein | HIGH (>100 mg/dL) | Mildly elevated | Very high (>200 mg/dL) |
| Gram stain | Positive ~70% | Negative | Negative (AFB occasionally +) |
D. Management
1. Emergency Resuscitation
- A: Airway - intubate if GCS <8 or respiratory failure
- B: High-flow O₂
- C: 2 large-bore IV cannulas; 20 mL/kg 0.9% NaCl bolus for septic shock; repeat up to 60 mL/kg if needed; early vasopressors (dopamine/noradrenaline) if unresponsive
- Treat DIC: FFP, platelets, cryoprecipitate as needed
- D: Treat seizures: IV lorazepam 0.1 mg/kg → phenobarbitone 20 mg/kg if refractory
2. Antibiotics - Start IMMEDIATELY (within 30 minutes)
Empirical regimen (infant >3 months):
| Drug | Dose | Rationale |
|---|
| Ceftriaxone | 80-100 mg/kg/day IV q12-24h | S. pneumoniae, N. meningitidis, H. influenzae |
| Vancomycin | 15 mg/kg IV q6h | Cover penicillin-resistant pneumococci (add in high-resistance regions) |
Add ampicillin if <3 months (to cover Listeria, which cephalosporins don't cover).
3. Dexamethasone
- 0.15 mg/kg IV q6h for 4 days, given 15-20 minutes before or with the first dose of antibiotics
- Reduces neuroinflammation; shown to reduce hearing loss in H. influenzae meningitis and neurological sequelae in pneumococcal meningitis
- Most benefit when given before antibiotics
4. Raised Intracranial Pressure Management
- Head of bed elevated 30°
- Avoid hypotonic fluids (risk of worsening cerebral oedema)
- Restrict fluids to 2/3 maintenance if SIADH is present
- Mannitol 0.25-0.5 g/kg IV if acute herniation signs
5. Duration of Antibiotics
| Organism | Duration |
|---|
| N. meningitidis | 7 days |
| S. pneumoniae | 10-14 days |
| H. influenzae | 7-10 days |
| Unknown | 14 days |
6. Complications to Monitor
- Hearing loss (most common sequela - BERA test before discharge)
- Subdural effusion (suspect if fever persists >5 days on treatment)
- Hydrocephalus
- Cerebral infarction / focal deficits
- Adrenal haemorrhage (Waterhouse-Friderichsen syndrome in meningococcaemia)
- Limb ischaemia / gangrene in meningococcaemia
7. Chemoprophylaxis for Close Contacts
- Rifampicin 10 mg/kg q12h for 2 days (all household/close contacts of meningococcal disease)
- Alternative: single dose ciprofloxacin (adults) or ceftriaxone IM (preferred in pregnancy)
- Prophylaxis does NOT cover pneumococcal meningitis
QUESTION 3 - Toddler / Preschool (1-5 years)
Scenario
A 2-year-old male is brought with 4 days of fever (39°C), cough, fast breathing, and refusal to feed. On examination: RR 52/min, nasal flaring, subcostal recessions, SpO₂ 91% on room air, temperature 39.1°C, dull percussion and reduced air entry over right lower zone. There is no stridor or wheeze. He is not immunised against pneumococcus.
Q: Discuss the diagnosis, investigations, and management.
ANSWER
A. Diagnosis
Primary Diagnosis: Community-Acquired Pneumonia (CAP) - Severe
WHO Classification of CAP severity in children:
| Category | Features | Management |
|---|
| Mild | Cough/cold, no fast breathing | Outpatient, oral antibiotics |
| Moderate (pneumonia) | Fast breathing, no danger signs | Oral amoxicillin, outpatient |
| Severe pneumonia | Fast breathing + chest indrawing | Admit, IV antibiotics |
| Very severe | Danger signs (cyanosis, unable to feed, convulsions, altered consciousness) | ICU |
This child has severe pneumonia: SpO₂ 91%, RR 52/min (>50 = fast for age 1-5), subcostal recessions, signs of lobar consolidation (dullness + reduced air entry right lower zone).
Danger signs present: SpO₂ <92%, inability to feed.
B. Causative Organisms by Age
| Age | Most Common Organisms |
|---|
| <2 months | GBS, gram-negatives, Chlamydia trachomatis |
| 2 months - 5 years | S. pneumoniae (most common bacterial), RSV/Influenza (viral), Mycoplasma (>2 years) |
| 5-15 years | S. pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae |
In this case (2 years, not immunised): S. pneumoniae is most likely.
C. Investigations
| Test | Purpose |
|---|
| CXR (AP) | Lobar/segmental consolidation (bacterial), diffuse interstitial (viral/Mycoplasma) |
| FBC | WBC >15,000 with neutrophilia = bacterial; <15,000 with lymphocytosis = viral |
| CRP/ESR | Elevated in bacterial |
| Blood culture | Positive in ~10-15% of bacterial CAP |
| Sputum culture | Usually not obtainable in toddlers |
| Nasopharyngeal swab | RSV, influenza, adenovirus PCR |
| Pulse oximetry | Continuous monitoring |
| Blood gas | If SpO₂ <90% or altered consciousness |
| Urine pneumococcal antigen | Useful if culture negative; sensitive in bacteraemic disease |
| Pleural fluid (if effusion) | Cell count, culture, pH, LDH, glucose - if parapneumonic effusion |
D. Management
1. Immediate Stabilisation
- Supplemental O₂ to maintain SpO₂ ≥94%
- Nasal cannula/face mask; HFNC or CPAP if failing
- IV/NG fluid support if unable to feed orally
- Antipyretics: paracetamol 15 mg/kg q4-6h
2. Antibiotic Therapy
Severe pneumonia (admitted, not immunised):
| Drug | Dose | Route | Rationale |
|---|
| Ampicillin | 50 mg/kg q6h | IV | S. pneumoniae, step-down once improving |
| OR Penicillin G | 50,000 units/kg q6h | IV | Equivalent to ampicillin for pneumococcus |
| + Azithromycin | 10 mg/kg/day | IV/PO | If atypical (Mycoplasma) suspected, age >2 yr |
- Switch to oral amoxicillin (80-90 mg/kg/day in 2-3 divided doses) once clinically improving, afebrile for 24h, SpO₂ stable on room air
- Add anti-staphylococcal cover (cloxacillin or vancomycin) if: post-influenza, cavitation, pneumatoceles, or severe sepsis → suspect MRSA/PVL-SA
Duration: 5-7 days for uncomplicated; 10-14 days for empyema/complicated.
3. Management of Complications
Parapneumonic effusion / empyema:
- Ultrasound-guided pleural tap - diagnostic + therapeutic
- Chest tube drainage for empyema
- Intrapleural fibrinolytics (urokinase) if loculated
- IV antibiotics extended (3-4 weeks)
- Add cover for Staphylococcus if not already
4. Criteria for Discharge
- Afebrile for 24 hours on oral antibiotics
- SpO₂ ≥94% on room air
- Tolerating oral feeds
- Clinically improving
5. Prevention
- Pneumococcal conjugate vaccine (PCV13/PCV15) at 2, 4, 6, 12-15 months
- Influenza vaccine annually
- This child's lack of PCV vaccination was a modifiable risk factor
QUESTION 4 - School Age (5-12 years)
Scenario
A 7-year-old girl presents with 3 days of fever (38.8°C), dysuria, frequency, left loin pain, and vomiting. She had a previous UTI 8 months ago. On examination: left renal angle tenderness, temperature 38.8°C, BP normal, HR 110. Urine dipstick: leucocytes 3+, nitrites positive, blood 1+.
Q: Discuss diagnosis, investigations, and management including long-term considerations.
ANSWER
A. Diagnosis
Primary Diagnosis: Acute Pyelonephritis (Upper UTI)
UTI classification:
| Type | Features |
|---|
| Lower UTI (cystitis) | Dysuria, frequency, suprapubic pain, afebrile or low-grade fever |
| Upper UTI (pyelonephritis) | Fever >38°C + loin pain/tenderness + systemic upset |
| Urosepsis | UTI + sepsis criteria (haemodynamic compromise) |
Risk factors for recurrent/complicated UTI in this girl:
- Female sex (short urethra)
- Previous UTI (recurrence risk 30-50%)
- Need to investigate for vesicoureteric reflux (VUR) or anatomical abnormality
B. Causative Organisms
| Organism | Frequency |
|---|
| E. coli | 75-90% of UTIs in children |
| Klebsiella pneumoniae | 5-10% |
| Proteus mirabilis | More common in boys (associated with foreskin flora) |
| Enterococcus faecalis | Less common |
| Staphylococcus saprophyticus | Adolescent girls |
C. Investigations
Urine Collection (Critical - method determines validity)
| Method | Contamination Risk | Use |
|---|
| Suprapubic aspiration | None (gold standard) | Infants, difficult cases |
| Catheter specimen | Minimal | All ages if continent |
| Mid-stream clean catch | Low-moderate | Children who can cooperate |
| Bag specimen | Very high - do NOT use for culture | Dipstick only |
Diagnosis requires:
- Positive dipstick (leucocytes + nitrites) AND
- Urine culture: ≥10⁵ CFU/mL of a single organism (clean catch) or ≥10⁴ (catheter)
Other Investigations
| Test | Rationale |
|---|
| FBC, CRP, ESR | Markers of severity; guide IV vs oral therapy |
| Blood culture | Obtain before antibiotics in pyelonephritis; bacteraemia in ~5% |
| Serum creatinine/urea | Baseline renal function |
| Electrolytes | |
| Renal ultrasound (US) | All children with first febrile UTI - look for hydronephrosis, duplex kidney, scarring |
| DMSA scan | Gold standard for renal scarring - perform 4-6 months after acute infection |
| MCUG (voiding cystourethrogram) | If US abnormal, or recurrent UTI - diagnose VUR grading |
D. Management
1. Antibiotic Treatment
This child has pyelonephritis with vomiting → admit for IV antibiotics:
| Drug | Dose | Notes |
|---|
| IV ceftriaxone | 50 mg/kg/day (max 1g) once daily | Empirical first choice; once daily convenient |
| OR IV cefotaxime | 100-150 mg/kg/day in 3 divided doses | Alternative |
| OR IV gentamicin | 7.5 mg/kg/day once daily | Excellent gram-negative cover; monitor levels |
- Switch to oral cefalexin or co-trimoxazole once afebrile 24-48h and tolerating orally (guided by sensitivities)
- Oral amoxicillin-clavulanate is an alternative (check local resistance patterns - E. coli resistance to amoxicillin alone >50% in most regions)
Duration: 7-14 days total (IV + oral) for pyelonephritis.
2. Supportive Care
- IV fluids: maintain adequate hydration (oral if tolerating)
- Antipyretics: paracetamol ± ibuprofen
- Adequate analgesia for loin pain
3. Long-Term Management (Crucial for School-Age)
Imaging follow-up pathway (NICE-based):
First febrile UTI in child >6 months
↓
Renal ultrasound within 6 weeks (urgent if atypical/recurrent)
↓
If abnormal or recurrent → MCUG (VUR grading)
↓
DMSA scan at 4-6 months post-infection (scarring assessment)
Vesicoureteric Reflux (VUR) grades:
| Grade | Description | Management |
|---|
| I-II | Mild, into ureter only | Antibiotic prophylaxis, watchful waiting |
| III | Into pelvis without dilatation | Prophylaxis ± surgical review |
| IV-V | Severe dilatation/hydronephrosis | Surgical correction (ureteric reimplantation) |
Antibiotic prophylaxis (e.g., trimethoprim 1-2 mg/kg nocte) for:
- Recurrent UTIs (≥2 episodes in 1 year)
- Grade III-V VUR
- Single functioning kidney
4. Bladder and Bowel Dysfunction (BBD)
- Screen for constipation and voiding dysfunction (extremely common cofactor)
- Treat constipation first - regular toileting, laxatives (polyethylene glycol)
- Bladder training: timed voiding, double voiding technique
5. Complications
- Renal scarring (reflux nephropathy) → hypertension, proteinuria, chronic kidney disease
- Recurrent pyelonephritis → progressive scarring
- Renal abscess (rare but occurs with delayed treatment)
QUESTION 5 - Adolescent (12-18 years)
Scenario
A 14-year-old girl, recently returned from a visit to South Asia, presents with 10 days of progressively worsening fever (step-ladder pattern rising to 40°C), headache, abdominal pain, constipation, and mild confusion over the past 2 days. On examination: she is toxic-looking, HR 90 (relative bradycardia), splenomegaly, faint rose-coloured spots on abdomen, and coated tongue.
Q: Discuss the diagnosis, investigations, and management.
ANSWER
A. Diagnosis
Primary Diagnosis: Enteric Fever (Typhoid Fever) - Salmonella typhi
Classic clinical constellation:
- Travel to endemic area (South/Southeast Asia, Africa, Latin America) - essential context
- Step-ladder fever pattern - rises daily, falls partially overnight
- Relative bradycardia (pulse-temperature dissociation - Faget's sign)
- Rose spots - 2-4 mm blanching maculopapular spots on anterior trunk (pathognomonic; in ~30%)
- Constipation (early) - later may develop diarrhoea in week 2-3
- Splenomegaly
- Confusion / altered sensorium = typhoid encephalopathy - serious complication
Why not another diagnosis?
- Malaria: cyclical fever, travel history overlaps - must exclude
- Dengue: haemorrhagic manifestations, thrombocytopenia, myalgia, no rose spots
- Infective endocarditis: heart murmur, embolic phenomena
- Infectious mononucleosis (EBV): pharyngitis, posterior cervical LN, monospot positive
B. Investigations
Definitive Tests
| Test | Expected Finding | Notes |
|---|
| Blood culture | S. typhi or S. paratyphi | Gold standard; 60-80% positive in week 1-2; take before antibiotics |
| Bone marrow culture | S. typhi | 90% sensitive; even after antibiotics; reserve for antibiotic-pre-treated cases |
| Stool culture | Positive in week 2-3 | Lower sensitivity |
| Urine culture | Positive in week 2-3 | |
| Widal test | O titre ≥1:160, H titre ≥1:160 | Low specificity; false positives with prior vaccination, other Salmonella. Useful in endemic areas when paired sera show 4-fold rise |
| Typhidot (IgM) | Positive | More sensitive than Widal in early disease; detects IgM anti-OMP |
| NS1/Dengue serology | Negative (to exclude dengue) | Always test in returning travellers |
| Malaria thick & thin film / RDT | Negative (to exclude malaria) | Cannot miss this |
Supporting Investigations
| Test | Findings in Typhoid |
|---|
| FBC | Leukopenia (WBC <4,000 - classic), anaemia, thrombocytopenia |
| CRP/ESR | Elevated |
| LFTs | Transaminitis (hepatitis occurs in ~40%) |
| LDH | Elevated |
| Serum electrolytes | Hyponatraemia |
| Stool microscopy | Exclude other GI infections |
C. Management
1. General Supportive Care
- Admit to hospital (this child is confused - severe disease)
- Bed rest, regular monitoring of vital signs
- Antipyretics: paracetamol (tepid sponging if needed)
- IV fluids if not tolerating orally or dehydrated
- Nutritious soft diet
- Isolation precautions: contact precautions; stool and urine are infectious
- Strict hand hygiene
2. Antibiotic Therapy
Antibiotic choice depends on regional sensitivity pattern:
| Drug | Dose | Notes |
|---|
| Ceftriaxone | 60-75 mg/kg/day (max 2.5g) IV once daily for 10-14 days | Drug of choice for severe/complicated disease; covers MDR strains |
| Azithromycin | 10-20 mg/kg/day (max 1g) PO for 5-7 days | Drug of choice for uncomplicated typhoid; excellent oral bioavailability |
| Ciprofloxacin | 15 mg/kg q12h PO/IV for 7-10 days | Only if confirmed fluoroquinolone-sensitive strain (resistance now widespread in South Asia) |
| Chloramphenicol | 75 mg/kg/day in 4 doses for 14 days | Historical first-line; now MDR widespread; avoid |
| Ampicillin/Co-trimoxazole | - | MDR resistance widespread in Indian subcontinent; not recommended empirically |
Exam point: Extensively drug-resistant (XDR) typhoid has emerged in Pakistan since 2016 (resistant to fluoroquinolones, ampicillin, chloramphenicol, co-trimoxazole, and 3rd-generation cephalosporins except ceftriaxone). Azithromycin is the current oral treatment for XDR typhoid.
3. Management of Complications
| Complication | Signs | Management |
|---|
| Intestinal perforation | Acute abdomen, peritonitis (week 3) | Surgical emergency + IV meropenem |
| GI bleeding | Bloody stool, haemodynamic collapse | Transfusion, surgical consult |
| Encephalopathy | Confusion, seizures | IV dexamethasone 3 mg/kg loading → 1 mg/kg q6h; ICU care |
| Myocarditis | ECG changes, troponin rise | Supportive; monitor |
| Hepatitis | Transaminitis | Supportive; avoid hepatotoxic drugs |
| Relapse (2-8% cases) | Fever recurs 1-3 weeks after stopping antibiotics | Repeat blood culture; re-treat with same antibiotic |
4. Monitoring Response
- Fever typically resolves in 3-7 days on ceftriaxone
- Failure to defervesce by day 5 → suspect resistance or complication → review cultures and sensitivities
- Repeat FBC, LFTs, blood culture at day 5-7
5. Prevention
- Typhoid vaccine: Vi polysaccharide vaccine (single IM dose, >2 years) or Ty21a oral live vaccine (>6 years) - recommended for travellers to endemic areas
- Food and water hygiene: eat thoroughly cooked food, drink bottled/boiled water
- Carrier state: Treat carriers (faecal excreters >12 months) with ciprofloxacin or ampicillin; may require cholecystectomy for chronic gallbladder carriers
EXAMINER'S MARKING GUIDE - What the Long Answer Must Include
For any pediatric infectious disease long answer, the examiner expects this structure:
| Section | Marks Allocated |
|---|
| Definition / Classification | 2 marks |
| Relevant history + risk factors from vignette | 3 marks |
| Differential diagnosis (≥3) | 3 marks |
| Causative organisms (age-appropriate) | 3 marks |
| Investigations - specific + rationale | 5 marks |
| CSF/lab interpretation table | 2 marks (bonus) |
| Management - initial stabilisation | 3 marks |
| Antibiotic choice + dose + duration | 5 marks |
| Supportive care | 2 marks |
| Complications + their management | 3 marks |
| Prevention / prophylaxis | 2 marks |
| Follow-up / long-term | 2 marks |
| Total | ~35 marks |
Golden rule: Always start with ABC stabilisation before antibiotics, always state dose and route for every drug you mention, and always include age-appropriate causative organisms - these are the three commonest mark-losers.Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.